The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high ...

The US Food and Drug Administration has approved US biotech Incyte’s (Nasdaq: INCY) Monjuvi (tafasitamab-cxix) with ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences’ twice-yearly injection to prevent HIV - a move the ...

Kraft Heinz and General Mills are removing synthetic food dyes from all U.S. products by 2027, aligning with new FDA ...

The US Food and Drug Administration (FDA) has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a ...

In a significant development in the global fight against HIV, the US Food and Drug Administration (FDA) has approved the long ...

Gilead Sciences, Inc., a biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

General Mills announced plans to eliminate all artificial colors from its U.S. foods by 2027, with the removal of synthetic dyes from cereals and foods served in schools set to take effect by the ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...